Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial

Bibliographic Details
Title: Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
Authors: Mukherjee, Somnath, Qi, Cathy, Shaw, Rachel, Jones, Christopher M., Bridgewater, John A., Radhakrishna, Ganesh, Patel, Neel, Holmes, Jane, Virdee, Pradeep S., Tranter, Bethan, Parsons, Philip, Falk, Stephen, Wasan, Harpreet S., Ajithkumar, Thankamma V., Holyoake, Daniel, Roy, Rajarshi, Scott-Brown, Martin, Hurt, Christopher N., O’Neill, Eric, Sebag-Montefiore, David, Maughan, Tim S., Hawkins, Maria A., Corrie, Pippa
Source: In European Journal of Cancer September 2024 209
Database: ScienceDirect
More Details
ISSN:09598049
DOI:10.1016/j.ejca.2024.114236
Published in:European Journal of Cancer
Language:English